Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Open House Drug Discount Agreements Melatonin Excluding Dosage Form 2 Mg Sustained Release Tablets Atc N05Ch01

Deadline: 05 Oct 2026

Germany

Ref. No.: 9719337

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Open House Drug Discount Agreements Chlorthalidone Atc C03Ba04

Deadline: 05 Oct 2026

Germany

Ref. No.: 9714773

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Open House Drug Discount Agreements Flupentixol Atc N05Af01

Deadline: 05 Oct 2026

Germany

Ref. No.: 9702638

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Erythropoietin Exclusively Epoetin Zeta Obo Atc B03Xa01 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9697195

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Glatiramer Acetate Prefilled Syringes Only Obo Atc L03Ax13 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9695254

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Elafibranor Obo Atc A05Ax06 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9695061

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Botulinum Toxin Type A Obo Atc M03Ax21 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9684736

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Clomipramine Obg Atc N06Aa04 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9681918

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Acquisition Of Rehabilitative Institutional Care

Deadline: 13 Nov 2025

Finland

Ref. No.: 9672261

EMD:Ref Document

Bid Value: Ref Document

11 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Guselkumab Only In The Strength 100 Mg Obo Atc L04Ac16 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9666289

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Acquisition Of Rehabilitative Institutional Care

Deadline: 13 Nov 2025

Finland

Ref. No.: 9665057

EMD:Ref Document

Bid Value: Ref Document

11 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dihydrocodeine Obg Atc R05Da14 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9664279

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code Sgb V For The Active Ingredient Cladribine Obo Atc L04Aa40 For The Period 01 12 2024 30 11 2026

Deadline: 05 Oct 2026

Germany

Ref. No.: 9652505

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Tobramycin Excl Hard Capsules With Powder For Inhalation Obo Atc J01Gb01 For The Period From 01 12 24 To

Deadline: 05 Oct 2026

Germany

Ref. No.: 9651914

EMD:Ref Document

Bid Value: Ref Document

337 Days Left

Dynamic Nanocluster Biomolecule Interfaces

Deadline: 30 Sep 2029

Finland

Ref. No.: 9576575

EMD:Ref Document

Bid Value: Ref Document

1428 Days Left

Showing 44866 to 44880 of 45218 results

‹
1
2
...
2989
2990
2991
2992
2993
2994
2995
...
3014
3015
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!